368 related articles for article (PubMed ID: 11770899)
1. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
Aliev G; Smith MA; Seyidov D; Neal ML; Lamb BT; Nunomura A; Gasimov EK; Vinters HV; Perry G; LaManna JC; Friedland RP
Brain Pathol; 2002 Jan; 12(1):21-35. PubMed ID: 11770899
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
3. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
[TBL] [Abstract][Full Text] [Related]
4. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: a new approach to therapy.
Sochocka M; Koutsouraki ES; Gasiorowski K; Leszek J
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):870-81. PubMed ID: 23469836
[TBL] [Abstract][Full Text] [Related]
5. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
[TBL] [Abstract][Full Text] [Related]
6. Vascular oxidative stress in Alzheimer disease.
Zhu X; Smith MA; Honda K; Aliev G; Moreira PI; Nunomura A; Casadesus G; Harris PL; Siedlak SL; Perry G
J Neurol Sci; 2007 Jun; 257(1-2):240-6. PubMed ID: 17337008
[TBL] [Abstract][Full Text] [Related]
7. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
8. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.
Kalaria RN
Neurobiol Aging; 2009 Sep; 30(9):1512-4. PubMed ID: 18187235
[TBL] [Abstract][Full Text] [Related]
9. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?
Aliyev A; Seyidova D; Rzayev N; Obrenovich ME; Lamb BT; Chen SG; Smith MA; Perry G; de la Torre JC; Aliev G
Neurol Res; 2004 Jul; 26(5):547-53. PubMed ID: 15265272
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview.
Carvalho C; Correia SC; Perry G; Castellani RJ; Moreira PI
J Neural Transm (Vienna); 2016 Feb; 123(2):107-11. PubMed ID: 25608860
[TBL] [Abstract][Full Text] [Related]
11. More support for vascular basis of Alzheimer's disease.
Becker-Barroso E
Lancet Neurol; 2005 Oct; 4(10):598-9. PubMed ID: 16208856
[No Abstract] [Full Text] [Related]
12. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
Aliev G; Smith MA; Obrenovich ME; de la Torre JC; Perry G
Neurotox Res; 2003; 5(7):491-504. PubMed ID: 14715433
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
[TBL] [Abstract][Full Text] [Related]
14. Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress.
Hong J; Hong SG; Lee J; Park JY; Eriksen JL; Rooney BV; Park Y
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1559-H1569. PubMed ID: 32383993
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
[TBL] [Abstract][Full Text] [Related]
16. Cerebral blood flow in Alzheimer's disease.
Roher AE; Debbins JP; Malek-Ahmadi M; Chen K; Pipe JG; Maze S; Belden C; Maarouf CL; Thiyyagura P; Mo H; Hunter JM; Kokjohn TA; Walker DG; Kruchowsky JC; Belohlavek M; Sabbagh MN; Beach TG
Vasc Health Risk Manag; 2012; 8():599-611. PubMed ID: 23109807
[TBL] [Abstract][Full Text] [Related]
17. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.
Iadecola C
Acta Neuropathol; 2010 Sep; 120(3):287-96. PubMed ID: 20623294
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.
Onyango IG; Khan SM
Curr Alzheimer Res; 2006 Sep; 3(4):339-49. PubMed ID: 17017864
[TBL] [Abstract][Full Text] [Related]
19. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.
Kalaria RN
Ann N Y Acad Sci; 1999; 893():113-25. PubMed ID: 10672233
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological evaluation of mixed dementia.
Jellinger KA; Attems J
J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
